Viewing Study NCT02229851


Ignite Creation Date: 2025-12-24 @ 11:45 PM
Ignite Modification Date: 2026-02-17 @ 10:27 PM
Study NCT ID: NCT02229851
Status: COMPLETED
Last Update Posted: 2020-11-23
First Post: 2014-08-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Placebo and Norditropin® FlexPro® (Somatropin) in Adults With Growth Hormone Deficiency.
Sponsor: Novo Nordisk A/S
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: NN8640-4054
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators